➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Johnson and Johnson
Mallinckrodt
Express Scripts
AstraZeneca
Colorcon

Last Updated: June 22, 2021

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 007073


Email this page to a colleague

« Back to Dashboard

NDA 007073 describes AZULFIDINE, which is a drug marketed by Pharmacia And Upjohn and Pfizer and is included in two NDAs. It is available from four suppliers. Additional details are available on the AZULFIDINE profile page.

The generic ingredient in AZULFIDINE is sulfasalazine. There are ten drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the sulfasalazine profile page.
Summary for 007073
Tradename:AZULFIDINE
Applicant:Pfizer
Ingredient:sulfasalazine
Patents:0
Formulation / Manufacturing:see details
Pharmacology for NDA: 007073
Suppliers and Packaging for NDA: 007073
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
AZULFIDINE EN-TABS sulfasalazine TABLET, DELAYED RELEASE;ORAL 007073 NDA Pfizer Laboratories Div Pfizer Inc 0013-0101 0013-0101-01 100 TABLET in 1 BOTTLE (0013-0101-01)
AZULFIDINE EN-TABS sulfasalazine TABLET, DELAYED RELEASE;ORAL 007073 NDA Pfizer Laboratories Div Pfizer Inc 0013-0101 0013-0101-10 1 BOTTLE in 1 CARTON (0013-0101-10) > 100 TABLET in 1 BOTTLE

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength500MG
Approval Date:Approved Prior to Jan 1, 1982TE:ABRLD:Yes

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:TABLET, DELAYED RELEASE;ORALStrength500MG
Approval Date:Apr 6, 1983TE:ABRLD:Yes

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
McKinsey
Express Scripts
Medtronic
Dow
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.